News Snapshot:
China has granted the first invention patent to a Covid-19 vaccine co-developed by biopharmaceutical firm CanSino Biologics Inc in the country, which experts said demonstrates the vaccine’s originality and creativity. According to a Global Times report, the vaccine is a recombinant adenovirus vaccine named Ad5-nCoV co-developed by CanSino with a team led by Chinese military infectious disease expert Chen Wei. “The grant of the patent further confirmed the vaccine’s efficacy and safety, and convincingly demonstrated the ownership of its intellectual property rights (IPR),†CanSino said in a statement on Sunday. An officially granted patent would enhance the market’s confidence in...
